Your browser doesn't support javascript.
loading
Distinct dynamics of mRNA LNPs in mice and nonhuman primates revealed by in vivo imaging.
Lemdani, Katia; Marlin, Romain; Mayet, Céline; Perkov, Vladimir; Pascal, Quentin; Ripoll, Manon; Relouzat, Francis; Dhooge, Nina; Bossevot, Laetitia; Dereuddre-Bosquet, Nathalie; Dargazanli, Gihad; Thibaut-Duprey, Kevin; Haensler, Jean; Chapon, Catherine; Prost, Christine; Le Grand, Roger.
Afiliação
  • Lemdani K; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Marlin R; Sanofi, Marcy-L'étoile, France.
  • Mayet C; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Perkov V; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Pascal Q; Sanofi, Marcy-L'étoile, France.
  • Ripoll M; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Relouzat F; Sanofi, Marcy-L'étoile, France.
  • Dhooge N; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Bossevot L; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Dereuddre-Bosquet N; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Dargazanli G; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Thibaut-Duprey K; Integrated Drug Discovery, Sanofi, Chilly-Mazarin, France.
  • Haensler J; Sanofi, Marcy-L'étoile, France.
  • Chapon C; Sanofi, Marcy-L'étoile, France.
  • Prost C; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Le Grand R; Sanofi, Marcy-L'étoile, France. christine.prost@sanofi.com.
NPJ Vaccines ; 9(1): 113, 2024 Jun 20.
Article em En | MEDLINE | ID: mdl-38902327
ABSTRACT
The characterization of vaccine distribution to relevant tissues after in vivo administration is critical to understanding their mechanisms of action. Vaccines based on mRNA lipid nanoparticles (LNPs) are now being widely considered against infectious diseases and cancer. Here, we used in vivo imaging approaches to compare the trafficking of two LNP formulations encapsulating mRNA following intramuscular administration DLin-MC3-DMA (MC3) and the recently developed DOG-IM4. The mRNA formulated in DOG-IM4 LNPs persisted at the injection site, whereas mRNA formulated in MC3 LNPs rapidly migrated to the draining lymph nodes. Furthermore, MC3 LNPs induced the fastest increase in blood neutrophil counts after injection and greater inflammation, as shown by IL-1RA, IL-15, CCL-1, and IL-6 concentrations in nonhuman primate sera. These observations highlight the influence of the nature of the LNP on mRNA vaccine distribution and early immune responses.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article